Investors Fear Tariffs, Advisors Fear Chaos — ETFs Are The Unexpected Middle Ground State Street Global Advisors' ETFs in Focus report shows disagreement between advisors and retail investors on portfolio risk. ETFs bridge the gap.
Options Corner: Political Turmoil Sets Up A Contrarian Call Spread For Bristol-Myers Squibb Although the Trump administration's healthcare policies pose risks for Bristol-Myers Squibb, the chaos opens a contrarian door for BMY stock.
Russell 2000 Holds At 24-Year Low Vs. S&P 500: Why Trump's Deregulation Could Spark A Turnaround The return to a more stable trade environment may create a short-term tailwind for small stocks, particularly those that derive the bulk of their revenues within the U.S.
Golden Gravity: Why 2025 May Be The Year Portfolios Come Back To Earth So far, 2025 feels like the year investors remember that real assets are not just relics. They are relevance.
US-China Trade Truce, Trump's Middle East Deals Spark Wall Street Rally: This Week In Markets U.S. and China cut tariffs by 115 points, sparking a stock rally and improving trade outlook. Trump secures $2 trillion in Gulf deals.
Cava Beats Q1 Expectations, Analyst Names It A 'Top Pick' Amid Expansion Push Cava tops Q1 estimates and earns "Top Pick" status as analyst eyes long-term growth through brand momentum and expansion plans.
Dick's Foot Locker Move Draws Skepticism As Analysts Question Game Plan Telsey Advisory analyst Joseph Feldman trimmed the price forecast for Dick's Sporting Goods from $250 to $220 while keeping an Outperform rating.
Acadia Pharmaceuticals (ACAD) Stock Explodes 26% After Patent Court Victory ACADIA Pharmaceuticals stock jumped 26.4% Friday afternoon. Shares gained following a favorable court ruling.
Bit Digital (BTBT) Shares Surge Despite Mining Revenue Decline Shares of Bit Digital Inc (
NASDAQ:BTBT ) jumped 14.6% to $2.36 on Friday afternoon after the company reported its first-quarter results, showcasing momentum in it
Rocket Pharma's Gene Therapy Shows Promise in ACM Patients, Says Analyst Chardan's Geulah Livshits raises target price for RCKT to $46 and maintains Buy rating after promising data on gene therapy for heart disease.
Birkenstock Keeps Its Footing, Ups Guidance Despite Global Uncertainty Birkenstock now expects FY25 revenue growth to be at the upper end of its prior guidance of 15% to 17% in constant currency.
CoreWeave Surges As Microsoft, OpenAI Deals Fuel Revenue Spike, Wall Street Boost Wall Street analysts raise PT on CRWV. JP Morgan maintains Overweight rating & raises PT from $43 to $66. Needham maintains Buy & raises PT from $55 to $78.
Carvana (CVNA) Stock Is Rising This Week: What's Going On? Carvana shares have jumped sharply after reporting Q1 earnings exceeding Wall Street expectations. Strong sales growth, profitability and raised guidance fueled the significant analyst price target increases.
AgMaster Report - Friday, May 16 Since Mid-April, July Corn has experienced a 60 cent break (500-440) – while discounting the Trump Tariffs & the prospects for a record crop of 15.8 BB.
Andreas Halvorsen Bets On A Healthy Comeback For UnitedHealth Ole Andreas Halvorsen of Viking Global Investors is betting on UnitedHealth Group, despite the healthcare sector's struggles, suggesting a long-term win.
NetScout Systems Stock Gets RS Rating Lift A Relative Strength Rating upgrade for NetScout Systems shows improving technical performance. Will it continue?
Roblox Stock Continues Winning Streak With Help From Rihanna Roblox stock advanced to a multiyear high on Friday, continuing a winning streak following its recent breakout.
Discover which S&P500 stocks are making waves on Friday. Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.
